Literature DB >> 7215946

Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease.

A Perperas, D Tsantoulas, B Portmann, A L Eddleston, R Williams.   

Abstract

Antibodies reacting with a liver membrane lipoprotein (LSP) have been detected by radioimmunoassay in the sera of 15 (27%) of 55 patients with alcohol-related liver lesions. There was a close association between the presence of the anti-LSP antibody and the findings on liver biopsy of a lymphocytic infiltrate in the portal tracts together with piecemeal necrosis of periportal hepatocytes. These histological features are characteristically found in the autoimmune disorder of chronic active hepatitis, in which anti-LSP antibodies are almost invariably present. It is suggested that in these cases of alcoholic liver disease there is loss of tolerance, and continued production of anti-LSP could promote periportal inflammation and accelerate the progression to cirrhosis. In the cases of acute alcoholic hepatitis without periportal inflammation studied, anti-LSP was not detected demonstrating that production of this autoantibody is not simply secondary to liver damage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7215946      PMCID: PMC1419225          DOI: 10.1136/gut.22.2.149

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2".

Authors:  U J Behrens; F Paronetto
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

Review 2.  Clinical relevance of the liver-specific lipoprotein (lsp).

Authors:  T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-06

3.  Experimental chronic active hepatitis in rabbits following immunization with human liver proteins.

Authors:  K H Büschenfelde; F K Kössling; P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

Review 4.  Antigens of the human liver.

Authors:  I G McFarlane; B M Wojcicka; R Williams
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

5.  Liver-specific protein in perspective.

Authors:  F V Chisari
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

6.  Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease.

Authors:  A M Cochrane; A Moussouros; B Portmann; I G McFarlane; A D Thomson; R Williams
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

7.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

8.  Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis.

Authors:  D M Jensen; I G McFarlane; B S Portmann; A L Eddleston; R Williams
Journal:  N Engl J Med       Date:  1978-07-06       Impact factor: 91.245

9.  Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis.

Authors:  D Tsantoulas; A Perperas; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  Sequential production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets.

Authors:  C S Lieber; L DeCarli; E Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

  10 in total
  16 in total

Review 1.  Alcoholic liver disease.

Authors:  A D Thomson; G L Bird; J B Saunders
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice.

Authors:  I I Slukvin; P J Boor; T R Jerrells
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

3.  Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases.

Authors:  T Numata; J Kato; Y Kohgo; S Katsuki; H Kondo; Y Niitsu
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

Review 4.  The pathogenesis of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

5.  Acetaldehyde alone may initiate hepatocellular damage in acute alcoholic liver disease.

Authors:  R E Barry; J D McGivan
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

6.  Antibodies directed against human liver specific membrane lipoprotein (LSP) in marmosets experimentally infected with the hepatitis A virus.

Authors:  D M Jensen; D A Peterson; L G Wolfe; T Hurley; J A Payne; J Ogden
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Purification and characterization of a liver cell membrane specific antigen.

Authors:  S Morichika; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-10

8.  Chronic hepatitis induced by alcohol.

Authors:  J Nei; Y Matsuda; A Takada
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

9.  Anti-LSP antibodies in acute liver disease.

Authors:  R Meliconi; A Perperas; D Jensen; A Alberti; I G McFarlane; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

10.  Ethanol metabolism in the generation of new antigenic determinants on liver cells.

Authors:  I R Crossley; J Neuberger; M Davis; R Williams; A L Eddleston
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.